Omeprazole‐induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype (English)

in British Journal of Clinical Pharmacology ; 69 , 5 ; 516-519
British Journal of Clinical Pharmacology

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT

• Omeprazole‐induced acute interstitial nephritis (OIAIN) is a rare adverse drug reaction. It is typically considered to be an idiosyncratic reaction affecting elderly patients. Omeprazole is a substrate for CYP2C19 and individuals who are homozygous variant for the null allele are poor metabolizers of this drug. These individuals have higher exposure to omeprazole. In the elderly metabolism of omeprazole is reported to be decreased despite a ‘normal activity’ genotype.

WHAT THIS PAPER ADDS

• The CYP2C19 poor metabolizer genotype was not over represented in patients with OIAIN. However, almost a third of the patients appeared to have deficient CYP2C19 function.

• Metabolism of omeprazole may be compromised in the elderly and caution should be exercised when using this medication in this group of patients.

AIM Omeprazole‐induced acute interstitial nephritis (OIAIN) is a rare adverse event. It is unknown if this is an idiosyncratic immune mediated reaction or if it relates to direct drug toxicity. Individuals who are homozygous for the variant alleles of CYP2C19 are poor metabolizers of omeprazole and have a greater exposure to the drug. The aim of this study was to determine the prevalence of the CYP2C19 poor metabolizer genotype and phenotype in patients with OIAIN.

METHODS Twenty patients were genotyped for the CYP2C19 variant alleles (*2, 681G>A and *3, 636G>A) by RFLP‐PCR analysis and eighteen phenotyped for CYP2C19 metabolizer status.

RESULTS The frequency of the CYP2C19*2 allelic variant was 12.5%, no *3 allelic variants were detected and no patient was a homozygous variant genotype. This was not different from the expected frequency. 33% of subjects were phenotypically CYP2C19 poor metabolizers.

CONCLUSIONS There was discordance between CYP2C19 genotype and phenotype. However, up to 45% of healthy elderly subjects have a poor metabolizer phenotype. Thus neither CYP2C19 poor metabolizer genotype nor phenotype is a risk factor for OIAIN.

How to get this document?
Download
Commercial Copyright fee: €37.98 Basic fee: €4.00 Total price: €41.98
Academic Copyright fee: €37.98 Basic fee: €2.00 Total price: €39.98

Document information


Table of contents – Volume 69, Issue 5

Show all volumes and issues

Tables of content are generated automatically and are based on records of articles contained that are available in the TIB-Portal index. Due to missing records of articles, the volume display may be incomplete, even though the whole journal is available at TIB.

423
Dysrhythmias associated with cocaine overdose
Ritter, JM | 2010
425
Icatibant
Dubois, Eline A. / Cohen, Adam F. | 2010
427
Role of voltage‐gated sodium, potassium and calcium channels in the development of cocaine‐associated cardiac arrhythmias
O'Leary, Michael E. / Hancox, Jules C. | 2010
443
Putting cocaine use and cocaine‐associated cardiac arrhythmias into epidemiological and clinical perspective
Wood, David M. / Dargan, Paul I. | 2010
448
Treatment of patients with cocaine‐induced arrhythmias: bringing the bench to the bedside
Hoffman, Robert S. | 2010
458
Activity of aclidinium bromide, a new long‐acting muscarinic antagonist: a phase I study
Schelfhout, Vanessa J. / Ferrer, Pau / Jansat, Josep Maria / Peris, Francesc / Gil, Esther Garcia / Pauwels, Romain A. / Joos, Guy F. | 2010
465
Population pharmacokinetics of intravenously and orally administered docetaxel with or without co‐administration of ritonavir in patients with advanced cancer
Koolen, Stijn L. W. / Oostendorp, Roos L. / Beijnen, Jos H. / Schellens, Jan H. M. / Huitema, Alwin D. R. | 2010
475
Intracellular and plasma steady‐state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre‐treated HIV‐infected patients
Ter Heine, Rob / Mulder, Jan Willem / Van Gorp, Eric C. M. / Wagenaar, Jiri F. P. / Beijnen, Jos H. / Huitema, Alwin D. R. | 2010
484
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
Nath, Christa E. / Shaw, Peter J. / Trotman, Judith / Zeng, Lihua / Duffull, Stephen B. / Hegarty, Gareth / McLachlan, Andrew J. / Gurney, Howard / Kerridge, Ian / Kwan, Yiu Lam et al. | 2010
498
Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine
Lal, Ritu / Sukbuntherng, Juthamas / Luo, Wendy / Vicente, Virna / Blumenthal, Robin / Ho, Judy / Cundy, Kenneth C. | 2010
508
Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects
Abdul, Mohi Iqbal Mohammed / Jiang, Xuemin / Williams, Kenneth M. / Day, Richard O. / Roufogalis, Basil D. / Liauw, Winston S. / Xu, Hongmei / Matthias, Anita / Lehmann, Reginald P. / McLachlan, Andrew J. | 2010
516
Omeprazole‐induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype
Helsby, Nuala A. / Lo, Wing‐Yee / Simpson, Ian J. / Voss, David M. / Logan, Kaye E. / Searle, Martin / Schollum, John B. W. / De Zoysa, Janak R. | 2010
520
Current dosing of low‐molecular‐weight heparins does not reflect licensed product labels: an international survey
Barras, Michael A. / Kirkpatrick, Carl M. J. / Green, Bruce | 2010
529
Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters
Cox, Anthony R. / Anton, Christopher / McDowell, Sarah E. / Marriott, John F. / Ferner, Robin E. | 2010
535
Medication use as a risk factor for inpatient falls in an acute care hospital: a case‐crossover study
Shuto, Hideki / Imakyure, Osamu / Matsumoto, Junichi / Egawa, Takashi / Jiang, Ying / Hirakawa, Masaaki / Kataoka, Yasufumi / Yanagawa, Takashi | 2010
543
Potentially inappropriate prescribing and cost outcomes for older people: a national population study
Cahir, Caitriona / Fahey, Tom / Teeling, Mary / Teljeur, Conor / Feely, John / Bennett, Kathleen | 2010
553
The recording of drug sensitivities for older people living in care homes
Alldred, David P. / Standage, Claire / Zermansky, Arnold G. / Barber, Nicholas D. / Raynor, D. K. / Petty, Duncan R. | 2010
558
Acute liver damage due to Serenoa repens: a case report
Lapi, Francesco / Gallo, Eugenia / Giocaliere, Elisa / Vietri, Michele / Baronti, Roberto / Pieraccini, Giuseppe / Tafi, Alessandro / Menniti‐Ippolito, Francesca / Mugelli, Alessandro / Firenzuoli, Fabio et al. | 2010
561
Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology
Montastruc, Jean‐Louis / Durrieu, Geneviève / Sommet, Agnès / Damase‐Michel, Christine / Lapeyre‐Mestre, Maryse | 2010
563
Translation Section
| 2010
571
Errata
| 2010

Similar titles